Literature DB >> 1546741

Atherogenic levels of low-density lipoprotein increase endocytotic activity in cultured human endothelial cells.

J A Holland1, K A Pritchard, N J Rogers, M B Stemerman.   

Abstract

Cultured human umbilical vein endothelial cells (EC) exposed to atherogenic low-density lipoprotein (LDL) levels for protracted periods demonstrated heightened endocytosis. Confluent EC were incubated with LDL 90 to 240 mg/dl cholesterol for 1 to 4 days and endocytosis was measured by 14C-sucrose uptake. Control EC and cells incubated with 90 mg/dl LDL cholesterol showed similar uptakes of 14C-sucrose during all measured time periods. In contrast, EC exposed to 240 mg/dl LDL cholesterol showed an increase in endocytosis beginning at 2 days, whereas 160 mg/dl LDL cholesterol promoted increased uptake by 4 days. The endocytotic activity of LDL-perturbed EC is reduced to levels seen in control cells by cytochalasin B, an actin polymerization inhibitor. This finding suggests a modulatory role for the cytoskeleton in endocytosis changes. Examination of LDL-perturbed EC cytoskeleton reveals structural remodeling resulting in a marked increase in stress fibers. Cytochalasin B exposure causes a loss of stress fibers with the formation of globular filamental aggregates. Such LDL-induced cellular functional changes may contribute mechanistically to endothelial dysfunction, which is widely held to be a major contributing factor in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1546741      PMCID: PMC1886169     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Microfilament bundles and the control of pinocytotic vesicle distribution at the surfaces of normal and transformed fibroblasts.

Authors:  I I Singer
Journal:  Exp Cell Res       Date:  1979-09       Impact factor: 3.905

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

3.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries.

Authors:  D C Schwenke; T E Carew
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

4.  Role of endothelial cells and their products in the modification of low-density lipoproteins.

Authors:  V W van Hinsbergh; M Scheffer; L Havekes; H J Kempen
Journal:  Biochim Biophys Acta       Date:  1986-08-14

5.  Low-density lipoprotein preparation by combined diafiltration and ultracentrifugation.

Authors:  K A Pritchard; J A Holland; N J Rogers; C C Crean; T E Britton; P Onigman; M B Stemerman
Journal:  Anal Biochem       Date:  1988-10       Impact factor: 3.365

6.  In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells.

Authors:  J F Nagelkerke; K P Barto; T J van Berkel
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

7.  Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin.

Authors:  M D Flanagan; S Lin
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

8.  Enhanced rates of fluid pinocytosis during exponential growth and monolayer regeneration by cultured arterial endothelial cells.

Authors:  P F Davies; S C Selden; S M Schwartz
Journal:  J Cell Physiol       Date:  1980-02       Impact factor: 6.384

9.  In vivo catabolism of biologically modified LDL.

Authors:  J F Nagelkerke; L Havekes; V W van Hinsbergh; T J van Berkel
Journal:  Arteriosclerosis       Date:  1984 May-Jun

10.  Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits.

Authors:  M E Haberland; D Fong; L Cheng
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

View more
  1 in total

Review 1.  Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.

Authors:  Xuesong Chen; Othman Ghribi; Jonathan D Geiger
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.